LogicVision Aktie
WKN DE: 542315 / ISIN: US54140W1071
10.03.2022 16:29:41
|
Longeveron Gains 10% Ahead Of Q4 Results
(RTTNews) - Shares of clinical stage biotechnology company Longeveron Inc. (LGVN) are climbing more than 10% Thursday morning ahead of fourth-quarter results, scheduled to be reported on Friday, March 11, before the market opens.
The company's lead investigational product LOMECEL-B is in Phase 1 and 2 studies in various indications, including aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome.
LGVN is at $7.85 currently. It has traded in the range of $2.84-$45 in the past 52 weeks.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu LogicVision Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |